Granahan Investment Management, LLC Harvard Bioscience Inc Transaction History
Granahan Investment Management, LLC
- $2.1 Billion
- Q2 2025
A detailed history of Granahan Investment Management, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Granahan Investment Management, LLC holds 1,501,508 shares of HBIO stock, worth $720,723. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,501,508
Previous 1,527,894
1.73%
Holding current value
$720,723
Previous $870,000
24.14%
% of portfolio
0.03%
Previous 0.05%
Shares
32 transactions
Others Institutions Holding HBIO
# of Institutions
77Shares Held
22.1MCall Options Held
8.7KPut Options Held
2K-
Amh Equity LTD3.51MShares$1.68 Million2.13% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.36 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.19MShares$1.05 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$889,8670.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.13MShares$540,6000.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $20M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...